Audit target · February 5, 2026
Modifier 25 Downcoding: What Payers Are Automating Now
Modifier 25 is the most examined modifier in dermatology because same-day procedures are the norm here rather than the exception. Several large commercial plans now reduce the E/M automatically when a procedure is on the same claim, before any human reviews the note.
What triggers the automated reduction
- An office E/M billed with a destruction, biopsy or excision on the same date, with no distinct diagnosis linked to the E/M line.
- A note where the history and exam read as pre-procedure evaluation rather than a separate problem.
- Repeated modifier 25 use at a rate far above the specialty norm across a single rendering provider.
What actually defends the claim
The defensible pattern is simple to state and harder to enforce: the note must show a separately identifiable problem that was evaluated and for which a decision was made, distinct from the decision to perform the procedure. A patient who arrives for a scheduled lesion removal and receives only that removal does not support modifier 25. The same patient who also raises a new rash, is examined for it and receives a management plan does.
We do not append modifier 25 to make a claim pay. Where the note does not support it, we tell the provider what was missing, because a paid claim that cannot survive a post-payment review is a liability rather than revenue.
Appealing a downcode
- Appeal with the note, not a letter. The note either shows the separate service or it does not.
- Point to the distinct diagnosis linked to the E/M line and the separate management decision in writing.
- Track downcode rates by payer and by provider monthly; a rising rate for one payer is a policy change, a rising rate for one provider is a documentation problem.
Frequently asked questions
Should we just stop using modifier 25?
No. Dropping it where it is supported gives away legitimate revenue on a large share of visits. The correct response is a documentation standard that makes the separate service visible in the note, plus an appeal process for automated reductions.
Does a different diagnosis code guarantee payment?
It helps, but no. A distinct diagnosis linked to the E/M line supports the claim; the note still has to show the separate evaluation and decision behind that diagnosis.
More updates
- Skin Substitute Application Codes: What Changed for 2026
- 2026 Fee Schedule: Conversion Factor and Dermatology RVU Shifts
- Biologic and JAK Inhibitor Prior Authorization Is Tightening
- Dermatopathology TC/26 Splits and Place-of-Service Edits
- Mohs Stage Counts and Repair Sequencing Under Post-Payment Review
